Expertise in
25
conditions

Dr. Erin E. Boh

Dermatology
University Healthcare System L.C.
1415 Tulane Ave, 
New Orleans, LA 
Accepting New Patients
Offers Telehealth
Referral required
Before you request
Expertise in
25
conditions
University Healthcare System L.C.
1415 Tulane Ave, 
New Orleans, LA 

Overview

Erin Boh is a Dermatologist practicing medicine in New Orleans, Louisiana.

Dr. Boh is highly rated in 25 conditions, according to our data. Her clinical expertise encompasses Psoriasis, Mycosis Fungoides, Cutaneous T-Cell Lymphoma (CTCL), and Plaque Psoriasis.

She is actively involved in clinical research, co-authoring 42 peer reviewed articles and participating in 4 clinical trials. Dr. Boh is currently accepting new patients.

Specialties

Dermatology

Licenses

Dermatology in LA

Hospital Affiliations

East Jefferson General Hospital
St Tammany Parish Hospital
University Medical Center New Orleans
Ochsner Medical Center Acute
Touro Infirmary

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Community First Health Plans
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Louisiana Healthcare Connections
  • HMO
  • MANAGED MEDICAID PLAN
Magnolia Health
  • HMO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Primewell Health Services
  • HMO
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE PART D
  • POS
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 15 Less Insurance Carriers -

Locations

University Healthcare System L.C.
1415 Tulane Ave, New Orleans, LA 70112

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
Enrollment Status: Completed
Publish Date: November 05, 2025
Intervention Type: Biological
Study Drug: Lebrikizumab
Study Phase: Phase 3
A Phase 3, 16-week, Randomized, Double-Blind, Placebo-Controlled, Parallel- Group Study to Assess the Impact of Lebrikizumab on Vaccine Responses in Adult Patients With Moderate-to-Severe Atopic Dermatitis
A Phase 3, 16-week, Randomized, Double-Blind, Placebo-Controlled, Parallel- Group Study to Assess the Impact of Lebrikizumab on Vaccine Responses in Adult Patients With Moderate-to-Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: October 17, 2023
Intervention Type: Drug
Study Drug: Lebrikizumab
Study Phase: Phase 3
An Open-Label, Single-Arm Study to Assess the Safety and Efficacy of Lebrikizumab in Adolescent Patients With Moderate-to-Severe Atopic Dermatitis
An Open-Label, Single-Arm Study to Assess the Safety and Efficacy of Lebrikizumab in Adolescent Patients With Moderate-to-Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: February 24, 2023
Intervention Type: Biological
Study Drug: Lebrikizumab
Study Phase: Phase 3
A Double Blind Randomized Vehicle Controlled Crossover Study to Evaluate the Safety and Efficacy of Topical Naloxone Hydrochloride Lotion 0.5% for the Relief of Pruritus in Patients With the MF or SS Forms of Cutaneous T-Cell Lymphoma
A Double Blind Randomized Vehicle Controlled Crossover Study to Evaluate the Safety and Efficacy of Topical Naloxone Hydrochloride Lotion 0.5% for the Relief of Pruritus in Patients With the MF or SS Forms of Cutaneous T-Cell Lymphoma
Enrollment Status: Terminated
Publish Date: October 28, 2022
Intervention Type: Drug
Study Drug: Naloxone Hydrochloride Lotion
Study Phase: Phase 3
View 3 Less Clinical Trials

42 Total Publications

Skin-Specific Outcomes of Brepocitinib in Patients With Dermatomyositis: Secondary Analysis of a Phase 3 Randomized Clinical Trial.
Skin-Specific Outcomes of Brepocitinib in Patients With Dermatomyositis: Secondary Analysis of a Phase 3 Randomized Clinical Trial.
Journal: JAMA dermatology
Published: August 26, 2026
Similar Doctors
Expertise in
56
conditions
Dr. Michael P. Lee
Dermatology
Expertise in
56
conditions
Dr. Michael P. Lee
Dermatology
Referral may be required
Before you request

A W Dermatopathology Service

3715 Prytania St Ste 306, 
New Orleans,, LA 
 (2.7 miles away)
504-896-9023
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Michael Lee is a Dermatologist practicing medicine in New Orleans,, Louisiana. Dr. Lee is highly rated in 56 conditions, according to our data. His clinical expertise encompasses Squamous Cell Skin Carcinoma, Basal Cell Skin Cancer, Bowen's Disease, and Extramammary Paget Disease. Dr. Lee is currently accepting new patients.

Expertise in
21
conditions
Expertise in
21
conditions
Referral required
Before you request

MD Claiborne And Associates Dermatology

410 W Judge Perez Dr, 
Chalmette, LA 
 (6.6 miles away)
504-603-2840
Languages Spoken:
English
See accepted insurances
Accepting New Patients

William C C Claiborne is a Dermatologist practicing medicine in Chalmette, Louisiana. Dr. C C Claiborne is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Keloids, Epidermoid Cyst, Impetigo, and Plaque Psoriasis. Dr. C C Claiborne is currently accepting new patients.

Expertise in
36
conditions
Expertise in
36
conditions
Referral may be required

Touro Infirmary

1401 Foucher St, 
New Orleans, LA 
 (2.3 miles away)
504-897-8418
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Pamela Martin is a Dermatologist practicing medicine in New Orleans, Louisiana. Dr. Martin is highly rated in 36 conditions, according to our data. Her clinical expertise encompasses Muir-Torre Syndrome, Hyperkeratosis Lenticularis Perstans, Hereditary Mucoepithelial Dysplasia, and Nakajo-Nishimura Syndrome. Dr. Martin is currently accepting new patients.

Frequently Asked Questions about Dr. Erin E. Boh

How do I make an appointment with Dr. Erin E. Boh?

You can book an appointment with Dr. Erin E. Boh by calling their office at 504-988-1700. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Erin E. Boh a top-rated expert for Psoriasis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Erin E. Boh is classified as an Distinguished expert for Psoriasis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Erin E. Boh specialize in?

While Dr. Erin E. Boh is a Dermatology, they have specific expertise in Psoriasis, Mycosis Fungoides, and Cutaneous T-Cell Lymphoma (CTCL). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Dermatology.

Does Dr. Erin E. Boh participate in research or clinical trials?

Yes. Dr. Erin E. Boh has published 42 articles and abstracts on conditions like Psoriasis. You can view a list of Dr. Erin E. Boh's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Erin E. Boh accept my insurance?

Dr. Erin E. Boh accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 504-988-1700 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Boh's expertise for a condition
ConditionClose
    View All 20 Advanced Conditions
    View All 61 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile